Perioperative management of chronic anticoagulation in orthopaedic surgery

Journal of the American Academy of Orthopaedic Surgeons

Volumn 18, Issue 12, 2010, Pages 729-738

  Thakur, Nikhil A ^a   Czerwein, John K ^a   Butera, James N ^b   Palumbo, Mark A ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650965346     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201012000-00003     Document Type: Review

References (61)

1. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E: The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 suppl):204S-233S.
2. Holbrook AM, Pereira JA, Labiris R, et al: Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165(10):1095-1106.
3. Vane JR, Boning RM: The mechanism of action of aspirin. Thromb Res 2003; 110(5-6):255-258.
4. Savi P, Nurden P, Nurden AT, LevyToledano S, Herbert JM: Clopidogrel: A review of its mechanism of action. Platelets 1998;9(3-4):251-255.
5. Garcia DA, Regan S, Henault LE, et al: Risk of thromboembolism with shortterm interruption of warfarin therapy. Arch Intern Med 2008;168(1):63-69.
6. Douketis JD, Bakhsh E: Perioperative management of antithrombotic therapy. Pol Arch Med Wewn 2008;118(4):201208.
7. Douketis JD: Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: A practical guide for clinicians. Thromb Res 2002;108(1):3-13.
8. Dunn AS, Turpie AG: Perioperative management of patients receiving oral anticoagulants: A systematic review. Arch Intern Med 2003;163(8):901-908.
9. Carrel TP, Klingenmann W, Mohacsi PJ, Berdat P, Althaus U: Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: An institutional review. J Heart Valve Dis 1999;8(4):392-398.
10. Jaffer AK, Brotman DJ, Chukwumerije N: When patients on warfarin need surgery. Cleve Clin J Med 2003;70(11): 973-984.
11. Dunn AS, Spyropoulos AC, Turpie AG: Bridging therapy in patients on longterm oral anticoagulants who require surgery: The Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). ; Thromb Haemost 2007;5(11):22112218.
12. Agnelli G, Becattini C: Treatment of DVT: How long is enough and how do you predict recurrence. J Thromb Thrombolysis 2008;25(1):37-44.
13. Kovich O, Otley CC: Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. ) Am Acad Dermatol 2003;48(2):233237.
14. Mukerji G, Munasinghe I, Raza A: A survey of the peri-operative management of urological patients on Clopidogrel. Ann R Coll Surg Engl 2009;91(4):313320.
15. Douketis JD, Berger PB, Dunn AS, et al: The perioperative management of antithrombotic therapy: American College of Chest Physicians evidencebased clinical practice guidelines (8th edition). Chest 2008;133(6 suppl):299S339S.
16. Horlocker TT, Wedel DJ, Benzon H, et al: Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28(3):172-197.
17. Wiedermann CJ, Stockner 1: Warfarininduced bleeding complications: Clinical presentation and therapeutic options. Thromb Res 2008;122(suppl 2):S13-S18.
18. Sachs RA, Smith JH, Kuney M, Paxton L: Does anticoagulation do more harm than good? A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty. J Arthroplasty 2003;18(4):389-395.
19. Ebraheim NA, Hoeflinger MJ, Savolaine ER, Jackson WT: Anterior compartment syndrome of the thigh as a complication of blunt trauma in a patient on prolonged anticoagulation therapy. Clin Orthop Relat Res 1991;263:180-184.
20. Griffiths D, Jones DH: Spontaneous compartment syndrome in a patient on long-term anticoagulation. J Hand Surg Br 1993;18(1):41-42.
21. Kirazli Y, Akkoc Y, Kanyilmaz S: Spinal epidural hematoma associated with oral anticoagulation therapy. Am J Phys Med Rehabil 2004;83(3):220-223.
22. Akoglu E, Seyfeli E, Akoglu S, Karazincir S, Okuyucu S, Dagli AS: Retropharyngeal hematoma as a complication of anticoagulation therapy. Ear Nose Throat J 2008;87(3):156-159.
23. Robbins M, Verghese J: Acute painless progressive quadriplegia associated with warfarin use. J Am Geriatr Soc 2007; 55(5):799-800.
24. Zeidman SM, Olivi A: Cervical intramedullary hemorrhage as a result of anticoagulant therapy. J Spinal Disord 1993;6(5):456-458.
25. Burger W, Chemnitius JM, Kneissl GD, Rücker G: Low-dose aspirin for secondary cardiovascular preventioncardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 2005; 257(5):399-414.
26. Joseph JJ, Pillai A, Bramley D: Clopidogrel in orthopaedic patients: A review of current practice in Scotland. Thromb J 2007;5:6.
27. Johanson NA, Lachiewicz PF, Lieberman JR, et al: American Academy of Orthopaedic Surgeons clinical practice guideline on: Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am 2009; 91(7):1756-1757.
28. Vandervelpen G, Goris L, Broos PL, Rommens PM: Functional sequelae in tibial shaft fractures with compartment syndrome following primary treatment with urgent fasciotomy [Dutch]. Acta Chir Belg 1992;92(5):234-240.
29. Werner CM, Pierpont Y, Pollak AN: The urgency of surgical debridement in the management of open fractures. J Am Acad Orthop Surg 2008;16(7):369-375.
30. Jensen RL: Cauda equina syndrome as a postoperative complication of lumbar spine surgery. Neurosurg Focus 2004; 16(6):e7.
31. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285(22):28642870.
32. O'Donnell M, Kearon C: Perioperative management of oral anticoagulation. Cardiol Clim 2008;26(2):299-309, viii.
33. Jaffer AK: Anticoagulation management strategies for patients on warfarin who need surgery. Cleve Clin J Med 2006; 73(suppl 1):S100-S105.
34. Kearon C, Hirsh J: Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336(21): 1506-1511.
35. Mann G, Hetsroni I, Mei-Dan O, et al: Deep vein thrombosis and thromboembolism in arthroscopic surgery [Hebrew]. Harefuah 2008; 147(10):797-800, 837.
36. Thachil J, Gatt A, Martlew V: Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg 2008;95(12):14371448.
37. Goldstein JN, Thomas SH, Frontiero V, et al: Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 2006; 37(1):151-155.
38. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF: Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77(3):477-480.
39. Sconce EA, Kamali F: Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: The need for a more tailored dosing regimen. Eur J Haematol 2006; 77(6):457-462.
40. Mann KG: Biochemistry and physiology of blood coagulation. Thromb Haemost 1999;82(2):165-174.
41. Hanslik T, Prinseau J: The use of vitamin K in patients on anticoagulant therapy: A practical guide. Am y Cardtovasc Drugs 2004;4(1):43-55.
42. Wentzien TH, O'Reilly RA, Kearns PJ: Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged. Chest 1998;114(6):1546-1550.
43. O'Donnell MJ, Kearon C, Johnson J, et ai: Brief communication: Preoperative anticoagulant activity after bridging lowmolecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 2007;146(3):184-187.
44. Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ: Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol 2004; 93(4):509-511.
45. Singelyn FJ, Verheyen CC, Piovella F, Van Aken HK, Rosencher N, EXPERT Study Investigators: The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: The EXPERT Study. Anesth Analg 2007;105(6):15401547.
46. Wille-Jargensen P: New therapeutic options in DVT prophylaxis. Orthopedics 2000;23(6 suppl):S639S642.
47. Di Giovanni CW: Current concepts review: Heparin-induced thrombocytopenia. Foot Ankle Int 2008;29(11):11581167.
48. Roderick P, Ferris G, Wilson K, et al: Towards evidence-based guidelines for the prevention of venous thromboembolism: Systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 2005;9(49):1-78.
49. Leon L, Rodriguez H, Tawk RG, Ondra SL, Labropoulos N, Morasch MD: The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery. Ann Vase Surg 2005; 19(3):442-447.
50. Hoff WS, Hoey BA, Wainwright GA, et al: Early experience with retrievable inferior vena cava filters in high-risk trauma patients. J Am Coll Surg 2004; 199(6):869-874.
51. Ferris EJ, McCowan TC, Carver DK, McFarland DR: Percutaneous inferior vena caval filters: Follow-up of seven designs in 320 patients. Radiology 1993; 188(3):851-856.
52. Van Ha TG, Chien AS, Funaki BS, et al: Use of retrievable compared to permanent inferior vena cava filters: A single-institution experience. Cardiovasc Intervent Radiol 2008;31(2):308-315.
53. Colwell CW Jr, Collis DK, Paulson R, et al: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999; 81(7):932-940.
54. Servin F: Low-dose aspirin and Clopidogrel: How to act in patients scheduled for day surgery. Curr Opin Anaesthesiol 2007;20(6):531-534.
55. Yusuf S, Zhao F, Mehta SR, et al: Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345(7):494-502.
56. Anekstein Y, Tamir E, Halperin N, Mirovsky Y: Aspirin therapy and bleeding during proximal femoral fracture surgery. Clin Orthop Relat Res 2004;418:205-208.
57. McMillian WD, Rogers FB: Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: A review. J Trauma 2009; 66(3):942-950.
58. Johansen A, White J, Turk A: Clopidogrel therapy: Implications for hip fracture surgery. Injury 2008;39(10): 1188-1190.
59. Schulz S, Schuster T, Mehilli J, et al: Stent thrombosis after drug-eluting stent implantation: Incidence, timing, and relation to discontinuation of Clopidogrel therapy over a 4 year period. Eur Heart J 2009;30(22):2714-2721.
60. Kulik A, Chan V, Ruel M: Antiplatelet therapy and coronary artery bypass graft surgery: Perioperative safety and efficacy. Expert Opin Drug Saf 2009;8(2):169182.
61. Chassot PG, Delabays A, Spahn DR: Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007;99(3):316-328.